Patients at five NHS centres in the North West are to take part in trials of a drugs that could help treat coronavirus.
Manufactured by pharmaceutical company Gilead, the drug Remdesivir is one of many being tested across the world as a treatment for Covid-19.
The trials have been fast-tracked and will take place in 15 NHS centres.
Remdesivir is a broad-spectrum antiviral agent that has been demonstrated in animal models against multiple emerging viral pathogens including Mers and Sars, which are also coronaviruses.
The North West centres are Liverpool University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Wythenshawe Hospital, the Pennine Acute Hospitals NHS Trust and Royal Lancaster Infirmary.
Remdesivir is an investigational agent and is not approved anywhere globally.
It has not been demonstrated to be safe or effective for any use.